HINT1 peptide/Hsp70 complex induces NK-cell-dependent immunoregulation in a model of autoimmune demyelination

European Journal of Immunology

Volumn 44, Issue 10, 2014, Pages 3026-3044

  Galazka, Grazyna ^a   Jurewicz, Anna ^a   Domowicz, Malgorzata ^a   Cannella, Barbara ^b   Raine, Cedric S ^b   Selmaj, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; Experimental autoimmune encephalomyelitis multiple sclerosis; Heat shock protein; Neuroimmunology; Tolerance Suppression

Indexed keywords

ADAPTOR PROTEIN; CD94 ANTIGEN; DAP10 PROTEIN; HEAT SHOCK PROTEIN 70; HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 1 HEAT SHOCK PROTEIN 70 COMPLEX; IMMUNOMODULATING AGENT; INTERLEUKIN 17; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; NEUROPROTECTIVE AGENT; NUCLEOTIDE BINDING PROTEIN; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG; HINT1 PROTEIN, MOUSE; NERVE PROTEIN; PEPTIDE; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NERVE FIBER; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SURFACE PROPERTY; ANIMAL; CELL SEPARATION; COCULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MASS SPECTROMETRY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL SEPARATION; COCULTURE TECHNIQUES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HSP70 HEAT-SHOCK PROTEINS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MASS SPECTROMETRY; MICE; NERVE TISSUE PROTEINS; NEUROIMMUNOMODULATION; PEPTIDES; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84925302405     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444694     Document Type: Article

References (55)

1. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004. 199: 971-979.
2. + T lymphocytes fail to suppress antigen specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 2006. 169: 4712-4716.
3. Winkler-Pickett, R., Young, H., Cherry, J. M., Diehl, J., Wine, J., Back, T. Bere, W. E. et al., In vivo regulation of experimental autoimmune encephalomyelitis by NK cells: alteration of primary adaptive responses. J. Immunol. 2008. 180: 4495-4506.
4. Morandi, B., Bramanti, P., Bonaccorsi, I., Montalo, E., Oliveri, D., Pezzino, G., Navarra, M. et al., Role of natural killer cells in the pathogenesis and progression of multiple sclerosis. Pharmacol. Res. 2008. 57: 1-5.
5. Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M. and Tabira, T., Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 1997. 186: 1677-1687.
6. Xu, W., Fazekas, G., Hara, H. and Tabira, T., Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2005. 163: 24-30.
7. Schleinitz, N., Vély, F., Harlé, J. R. and Vivier, E., Natural killer cells in human autoimmune diseases. Immunology 2010. 131: 451-8.
8. Bielekova, B. and Martin, R., Multiple sclerosis: immunotherapy. Curr. Treat Options Neurol. 1999. 1: 201-220.
9. Tian, Z., Gershwin, M. E. and Zhang, C., Regulatory NK cells in autoimmune disease. J. Autoimmun. 2012. 39: 206-215.
10. Smeltz, R. B., Wolf, N. A. and Swanborg, R. H., Inhibition of autoimmune T cells response in the DA rat by bone marrow-derived NK cells in vitro: implication for autoimmunity. J. Immunol. 1999. 163: 1390-1397.
11. Lodoen, M. B. and Lanier, L. L., Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 2006. 18: 391-398.
12. Vievier E, Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M. et al., Innate or adaptive immunity? The example of natural killer cells. Science 2011. 33: 144-149.
13. Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E. et al., Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001. 97: 3146-3151.
14. Cooper, M. A., Fehniger, T. A. and Caligiuri, M. A., The biology of human natural killer-cell subsets. Trends Immunol. 2001. 22: 633-640.
15. Beziat, V., Duffy, D., Quoc, S. N., Le Garff-Tavernier, M., Decocq, J., Combadière, B., Debré, P. et al., CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation. J. Immunol. 2011. 186: 6753-6761.
16. dim NK cells. Scand. J. Immunol. 2007. 65: 126-138.
17. Hayakawa, Y., Huntington, N. D., Nutt, S. L. and Smyth, M. J., Functional subsets of mouse natural killer cells. Immunol. Rev. 2006. 214: 47-55.
18. Hayakawa, Y., Andrews, D. M. and Smyth, M. J., Subset analysis of human and mouse mature NK cells. Methods Mol. Biol. 2010. 612: 27-38.
19. Fu, B., Wang, F., Sun, R., Ling, B., Tian, Z. and Wei, H., CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. Immunology 2011. 133: 350-359.
20. Blasius, A. L., Barchet, W., Cella, M. and Colonna, M., Development and function of murine B220+CD11+NK1.1+ cells identify them as a subset of NK cells. J. Exp. Med. 2007. 204: 2561-2568.
21. Bielekova, B., Catalfamo, M., Reichert-Scrivner, S., Packer, A., Cerna, M., Waldmann, T. A., McFarland, H. et al., Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl. Acad. Sci. USA 2006. 103: 5941-5946.
22. Sun, J. C., Beilke, J. N. and Lanier, L. L., Adaptive immune features of natural killer cells. Nature 2009. 4575: 57-61.
23. Strowig, T., Brilot, F. and Munz, C., Noncytotoxic function of NK cells: directed pathogen restriction and assistance to adaptive immunity. J. Immunol. 2008. 180: 7785-7791.
24. Galazka, G., Stasiolek, M., Walczak, A., Jurewicz, A., Zylicz, A., Brosnan, C. F., Raine, C. S. et al., Brain-derived heat shock protein70-peptide complexes induce NK cell-dependent tolerance to experimental autoimmune encephalomyelitis. J. Immunol. 2006. 176: 1588-1599.
25. Galazka, G., Jurewicz, A., Orlowski, W., Stasiolek, M., Brosnan, C. F., Raine, C. S. and Selmaj, K., EAE tolerance induction with hsp70-peptide complexes depends on H60 and NKG2D activity. J. Immunol. 2007. 179: 4503-4512.
26. Alter G., Malenfant, J. M. and Altfeld, M., CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 2004. 294: 15-22.
27. Vivier, E., Tomasello, E., Baratin, M., Walzer, T. and Ugolini S., Functions of natural killer cells. Nat. Immunol. 2008. 9: 503-510.
28. Liu Q., Puche, A. C. and Wang, J. B., Distribution and expression of protein kinase C interactive protein (PKCI/HINT1) in mouse central nervous system (CNS). Neurochem. Res. 2008. 33: 1263-1276.
29. Durelli, L., Conti, L., Clerico, M., Boselli, D., Contessa, G., Ripellino, P., Ferrero, B. et. al., T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann. Neurol. 2009. 65: 499-509.
30. Gross, C., Hansch, D., Gastpar, R. and Mulhoff, G., Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol. Chem. 2003. 384: 267-279.
31. Gross, C., Schmidt-Wolf, I. D., Nagaraj, S., Gastpar, R., Ellwart, J., Kunz-Schughart, L. A. and Mulhoff, G., Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells. Cell Stress Chaperones 2003. 8: 348-360.
32. Multhoff, G., Mizzen, L., Winchester, C. C., Milner, C. M., Wenk, S., Eissner, G., Laumbacher, H. H. et al., Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells. Exp. Hematol. 1999. 27: 1627-1636.
33. Weiske, J. and Huber, O., The histidine triad protein Hint1 interact with Pontin and Reptin and inhibits TCF-beta-catenin-mediated transcription. J. Cell Sci. 2005. 118: 3117-3129.
34. Choi, E. K., Rhee, Y. H., Park, H. J., Ahd, S. D., Shin, K. H. and Park, K. K., Effect of protein kinase C inhibitor (PKCI) on radiation sensitivity and c-fos transcripton. Int. J. Radiat. Oncol. Biol. Phys. 2001. 49: 397-405.
35. Razin, E., Zhang, Z. C., Nechushtan, H., Frenkel, S., Lee, Y. N., Arudchandran, R. and Rivera, J., Suppression of microphthalmia transcriptional activity by its association with protein kinase C-interacting protein 1 in mast cells. J. Biol. Chem. 1999. 274: 34272-34276.
36. Renedo, M., I. Arce, A. Rodriguez, Carretero, M., Lanier, L. L., Lopez-Botet, M. and Fernandez-Ruiz, E., The human natural killer gene complex is located on chromosome 12p12-p13. Immunogenetics 1997. 46: 307-311.
37. Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E. and Brooks, A. G., Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 1998. 187: 813-818.
38. Borrego, F., Masilamani, M., Marusina, A. I., Tang, X. and Coligan, J. E., The CD94/NKG2 family of receptors. Immunol. Res. 2006. 35: 263-277.
39. Jensen, H., Folkersen, L. and Skov, S., Regulation and gene expression profiling of NKG2D positive human cytomegalovirus-primed CD4(+) T-cells. PLoS One 2012. 7: e41577.
40. Brady, J., Carotta, S., Thong, R. P., Chan, C. J., Hayakawa, Y., Smyth, M. J. and Nutt, S. L., The interactions of multiple cytokines control NK cell maturation. J. Immunol. 2010. 185: 6679-6688.
41. Chiossone, L., Chaix, J., Fuseri, N., Roth, C., Vivier, E. and Walzer, T., Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009. 113: 5488-5496.
42. Gordon, S. M., Chaix, J., Rupp, L. J., Wu, J., Madera, S., Sun, J. C., Lindsten, T. et al., The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 2012. 36: 55-67.
43. Hayakawa, Y. and Smyth, M. J., CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 2006. 176: 1517-1524.
44. Kim, S., Iizuka, K., Kang, H. S., Dokun, A., French, A. R., Greco, S. and Yokoyama, W.M., In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 2002. 3: 523-528.
45. Srivastava, R. M., Varalakshmi, C. and Khar, A., The ischemia-responsive protein 94 (Irp94) activates dendritic cells through NK cell receptor protein-2/NK group 2 member D (NKR-P2/NKG2D) leading to their maturation. J. Immunol. 2008. 180: 1117-1130.
46. Srivastava, R. M., Varalakshmi, Ch. and Khar, A., Cross-linking a mAb to NKR-P2/NKG2D on dendritic cells induces their activation and maturation leading to enhanced anti-tumor immune response. Int. Immunol. 2007. 19: 591-607.
47. Saether, P. C., Hoelsbrekken, S. E., Fossum, S. and Dissen, E., Rat and mouse CD94 associate directly with the activating transmembrane adaptor proteins DAP12 and DAP10 and activate NK cell cytotoxicity. J. Immunol. 2011. 187: 6365-6373.
48. Couder, J. D., Scarpellino, L., Gros, F., Vivier, E. and Held, W., Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. Blood 2009. 111: 3571-3578.
49. Hyka-Nouspikel, N. and Phillips, J. H., Physiological roles of murine DAP10 adapter protein in tumor immunity and autoimmunity. Immunol. Rev. 2006. 214: 106-117.
50. Zingoni, A., Sornasse, T., Cocks, B. G., Tanaka, Y., Santoni, A. and Lanier, L. L., NK cell regulation of T cell-mediated responses. Mol. Immunol. 2005. 42: 451-454.
51. Shi, F. D. and Van, K. L., Reciprocal regulation between natural killer cells and autoreactive T cells. Nat. Rev. Immunol. 2006. 6: 751-760.
52. Tay, C. H., Yu, L. Y., Kumar, V., Mason, L., Ortaldo, J. R. and Welsh, R. M., The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. J. Immunol. 1999. 162: 718-726.
53. Biron, C. A., Nguyen, K. B. and Pien, G. C., Innate immune responses to LCMV infections: natural killer cells and cytokines. Curr. Top. Microbiol. Immunol. 2002. 263: 7-27.
54. Huang, D., Shi, F. D., Jung, S., Pien, G. C., Wang, J., Salazar-Mather, T. P., He, T. T. et al., The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 2006. 20: 896-905.
55. Hao, J., Liu, R., Piao, W., Zhou, Q., Vollmer, T. L., Campagnolo, D. I., Xiang, R. et al., Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J. Exp. Med. 2010. 207: 1907-1921.